A PD Solution to Protect Peritoneal Membranes
PD-protec® by Zytoprotec, which now has FDA orphan drug status, is in Phase III trials among 300 patients in the US and Europe. The product aims to reduce PD complications such as peritonitis and membrane failure.
Read the full article » | Posted 01-11-2018
Related Articles
- Medical Device Transforms Fluid Removal in Kidney Care Posted 07-13-2022
- Phraxis, Inc Seeking FDA 510(k) Clearance for InterGraft Posted 05-12-2022
- Axess Shows Promise for Living HD Grafts Posted 05-12-2022
- Invizius to Assess Way to Protect Peritoneal Membranes Posted 05-12-2022